Connection
Naghmehossadat Eshghi to Skin Neoplasms
This is a "connection" page, showing publications Naghmehossadat Eshghi has written about Skin Neoplasms.
|
|
Connection Strength |
|
|
|
|
|
0.422 |
|
|
|
-
Eshghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab. Clin Nucl Med. 2018 May; 43(5):e142-e144.
Score: 0.422